Response to Spangenberg and Koo, "Response to Schwarz C.W., et al. 'Comparative 2-year drug survival of bimekizumab and brodalumab in second-line treatment of psoriasis".

Authors

Christopher Willy Schwarz, Nikolai Loft, Lone Skov

Published in

Journal of the American Academy of Dermatology. Oct 05, 2026. Epub Oct 05, 2026.

PMID:
42833492
Bibliographic data and abstract were imported from PubMed on 06 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.